Preclinical research efforts have examined multi-stage antigen constructs for malaria including Pfs25 and CSP using fusion antigens displayed on a viral vector27, and Pfs25 and P. falciparum merozoite surface protein 1 (MSP1) admixed with an emulsion of synthetic MPLA in a stable squalene-in-water emulsion28. The gene discussed is DNAJC5; the disease is malaria.